Dusetzina SB, Castle G, Han J, Leech AA, Zhu J. Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements. JAMA. 2026 Apr 2;e262615. doi:10.1001/jama.2026.2615
Zhang Y, Ratcliff GE, Zhu J. Cutting Costs, Saving Lives: A Surgeon’s Guide to the Foundations of Cost-effectiveness Analysis. J Surg Res. 2026 Jan 28;318:366–78.
Zhang Y, Ratcliff GE, Zhu J. Beyond the Basics of Cost-effectiveness Methods: Advanced Methods for Surgical Decision-making. J Surg Res. 2026 Jan 20;318:255–63.
Zhu J*, Jhang J*, Yu H, Mushlin AI, Kamel H, Alemayehu N, Giardina JC, Gupta A, Pandya A. Cost-Effectiveness of Risk-Based Screening for Asymptomatic Carotid Artery Stenosis. MDM Policy & Practice. 2026 Jan 1;11(1):23814683251409213. (*Co-first authors)
Chen T, Zhu J, Tsuei S, Jiang Y, Zheng Y, Xu D, Fu H. Health and economic effects of increased taxation on tobacco, alcohol, and sugar-sweetened beverages in China: a modelling study. Lancet Public Health. 2025 Dec;10(12):e1025–35.
Pandya A, Zhu J, Luviano A, James LP, Goshua G. A threshold inequality aversion parameter (TIAP) approach to interpret distributional cost-effectiveness analysis results. Value Health. 2025 Oct 13;S1098-3015(25)05621-9.
Leech AA, Zhu J, Peterson H, Martin MH, Ratcliff G, Garbett S, Graves JA. Modeling Disability-Adjusted Life-Years for Policy and Decision Analysis. Med Decis Making. 2025 May 28;272989X251340077.
Zhu J, Kim KWR, Yu H, Gupta A, Mushlin AI, Kamel H, et al. Acute Ischemic Stroke Care Quality Improvement. JAMA Neurol. 2025 Jan 13
Zhu J, Kamel H, Gupta A, Mushlin AI, Menzies NA, Gaziano TA, Rosenthal MB, Pandya A. Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness Analysis. Ann Intern Med. 2023 May;176(5):649–57.
Zhu J, Lyatuu G, Sudfeld CR, Kiravu A, Sando D, Machumi L, et al. Re-evaluating the health impact and cost-effectiveness of tuberculosis preventive treatment for modern HIV cohorts on antiretroviral therapy: a modelling analysis using data from Tanzania. Lancet Glob Health. 2022 Nov;10(11):e1646–54.
2022 Top 3 Cost-Effectiveness Analysis Paper of the Year, Tufts CEA Registry
Pandya A, Paulden M, Zhu J, Lavelle TA, Hammitt J. Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates. Med Decis Making. 2022 May 7;272989X221097106. 2020
Spahillari A*, Zhu J*, Ferket BS, Hunink MGM, Carr JJ, Terry JG, Nelson C, Mwasongwe S, Mentz RJ, O’Brien EC, Correa A, Shah RV, Murthy VL, Pandya A. Cost-effectiveness of Contemporary Statin Use Guidelines With or Without Coronary Artery Calcium Assessment in African American Individuals. JAMA Cardiol. 2020 Aug 1;5(8):871–80.
(*Co-first authors)
Pandya A, Doran T, Zhu J, Walker S, Arntson E, Ryan AM. Modelling the cost-effectiveness of pay-for-performance in primary care in the UK. BMC Med. 2018 Aug 29;16(1):135.
Top 3 Cost-Effectiveness Analysis Paper of the Year | Tufts CEA Registry | 2022
Dissertation Completion Fellowship | Harvard Graduate School of Arts & Sciences | 2021-2022
Harvard China Health Partnership Research Award | Harvard China Health Partnership | 2020
Lee B. Lusted Student Prize Stephen Pauker Award for Quantitative Methods and Theoretical Development |The Society for Medical Decision Making (SMDM) | 2019